Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.50 |
| ▸ | CES1 | P23141 | 7/20 | 0.48 |
| ▸ | CPA1 | P15085 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 3/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL27963324 | 1.00 | CYP3A4 (0.57) | CYP3A4TDP1ESR1ESR2CES1 | |
| Trifluoroacetic Acid SCHEMBL27516099 | 0.98 | CYP3A4 (0.55) | CYP3A4TDP1ESR1ESR2CES1 | |
| Trifluoroacetic Acid SCHEMBL27511572 | 0.98 | CYP3A4 (0.55) | CYP3A4TDP1ESR1ESR2CES1 | |
| Trifluoroacetic Acid SCHEMBL30195537 | 0.98 | CYP3A4 (0.55) | CYP3A4TDP1ESR1ESR2CES1 | |
| Trifluoroacetic Acid SCHEMBL11783673 | 0.98 | CYP3A4 (0.55) | CYP3A4TDP1ESR1ESR2CES1 | |
| Trifluoroacetic Acid SCHEMBL27870901 | 0.98 | CYP3A4 (0.55) | CYP3A4TDP1ESR1ESR2CES1 | |
| Trifluoroacetic Acid SCHEMBL18425261 | 0.98 | CYP3A4 (0.55) | CYP3A4TDP1ESR1ESR2CES1 | |
| Trifluoroacetic Acid SCHEMBL31532238 | 0.98 | CYP3A4 (0.55) | CYP3A4TDP1ESR1ESR2CES1 | |
| Trifluoroacetic Acid SCHEMBL1081998 | 0.94 | CYP3A4 (0.50) | CYP3A4TDP1ESR1ESR2CES1 | |
| SCHEMBL28891740 | 0.88 | CYP3A4 (0.55) | CYP3A4TDP1ESR1ESR2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0455119-A2 | Process for the preparation of canthaxanthin and astaxanthin | BASF Aktiengesellschaft (DE) | 1991-11-06 | — | — | EP | claimed |
| JP-4225933-A | — | — | None | — | — | JP | disclosed |
| CN-114341215-B | Curable composition | 株式会社日本触媒 | 2024-12-27 | — | — | CN | disclosed |
| US-20240352203-A1 | FILM-FORMING MATERIAL FOR SEMICONDUCTOR, MEMBER-FORMING MATERIAL FOR SEMICONDUCTOR, PROCESS MEMBER-FORMING MATERIAL FOR SEMICONDUCTOR, UNDERLAYER FILM-FORMING MATERIAL, UNDERLAYER FILM, AND SEMICONDUCTOR DEVICE | ADEKA CORPORATION (JP) | 2024-10-24 | — | — | US | disclosed |
| EP-4375750-A1 | FILM-FORMING MATERIAL FOR SEMICONDUCTOR, MEMBER-FORMING MATERIAL FOR SEMICONDUCTOR, PROCESS MEMBER-FORMING MATERIAL FOR SEMICONDUCTOR, UNDERLAYER FILM-FORMING MATERIAL, UNDERLAYER FILM, AND SEMICONDUCTOR DEVICE | ADEKA CORPORATION (JP) | 2024-05-29 | — | — | EP | disclosed |
| CN-117616337-A | Film forming material for semiconductor, member forming material for semiconductor, process member forming material for semiconductor, underlayer film forming material, underlayer film, and semiconductor device | 株式会社艾迪科 | 2024-02-27 | — | — | CN | disclosed |
| CN-114341215-A | Curable composition | 株式会社日本触媒 | 2022-04-12 | — | — | CN | disclosed |
| US-20180243984-A1 | METHOD FOR MANUFACTURING THREE-DIMENSIONAL OBJECT AND METHOD FOR PREPARING DATA FOR NOZZLE MOVEMENT PATH TO BE USED THEREIN, AND APPARATUS FOR MANUFACTURING THREE-DIMENSIONAL OBJECT AND PROGRAM FOR PREPARING DATA FOR NOZZLE MOVEMENT PATH TO BE USED THEREIN | JSR CORPORATION (JP) | 2018-08-30 | — | — | US | disclosed |
| EP-3335862-A1 | METHOD FOR MANUFACTURING THREE-DIMENSIONAL MODELED OBJECT AND NOZZLE MOVEMENT PATH DATA CREATION METHOD USED IN SAME, AND DEVICE FOR MANUFACTURING THREE-DIMENSIONAL MODELED OBJECT AND NOZZLE MOVEMENT PATH DATA CREATION PROGRAM USED IN SAME | JSR Corporation (JP) | 2018-06-20 | — | — | EP | disclosed |
| US-9707244-B2 | Compositions and methods for treating conditions that affect epidermis | GENCIA CORPORATION (US) | 2017-07-18 | — | — | US | disclosed |
| US-20160022709-A1 | Compositions and Methods for Treating Conditions that Affect Epidermis | GENCIA CORPORATION | 2016-01-28 | — | — | US | disclosed |
| CN-102341731-B | Coloring composition, color filter and color liquid crystal display element | JSR CORP | 2014-06-25 | — | — | CN | disclosed |
| CN-102341731-A | Coloring composition, color filter and color liquid crystal display element | JSR CORP | 2012-02-01 | — | — | CN | disclosed |
| WO-1999047498-A1 | UNIVERSAL LINKER FOR COMBINATORIAL SYNTHESIS | PHARMACOPEIA, INC. (US) | 1999-09-23 | — | — | WO | disclosed |
| US-5210314-A | PREPARATION OF CANTHAXANTHIN AND ASTAXANTHIN | BASF AKTIENGESELLSCHAFT (DE) | 1993-05-11 | — | — | US | disclosed |
| US-5210314-A | PREPARATION OF CANTHAXANTHIN AND ASTAXANTHIN | BASF AKTIENGESELLSCHAFT (DE) | 1993-05-11 | — | — | US | disclosed |
| JP-H04225933-A | PREPARATION OF CANTHAXANTHIN AND ASTAXANTHIN | BASF AG | 1992-08-14 | — | — | JP | disclosed |
| EP-0455119-A2 | Process for the preparation of canthaxanthin and astaxanthin | BASF Aktiengesellschaft (DE) | 1991-11-06 | — | — | EP | disclosed |
| EP-0455119-A2 | Process for the preparation of canthaxanthin and astaxanthin | BASF Aktiengesellschaft (DE) | 1991-11-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160022709-A1 | Compositions and Methods for Treating Conditions that Affect Epidermis | KRT18, CUTA, GLA | CYP3A4 4494/4885TDP1 545/4885ESR1 977/4885 |
| US-20240352203-A1 | FILM-FORMING MATERIAL FOR SEMICONDUCTOR, MEMBER-FORMING MATERIAL FOR SEMICONDUCTOR, PROCESS MEMBER-FORMING MATERIAL FOR SEMICONDUCTOR, UNDERLAYER FILM-FORMING MATERIAL, UNDERLAYER FILM, AND SEMICONDUCTOR DEVICE | FBXL19, SRSF9, CNOT9 | CYP3A4 963/4885TDP1 3567/4885ESR1 468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.